Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2003
08/19/2003US6607728 Compounds and methods for the diagnosis and treatment of ehrlichia infection
08/19/2003US6607726 Human tumor necrosis factor receptor TR10
08/19/2003US6607724 Administering fragments, conformations, biological equivalent, or derivatives of antithrombin III; anticancer agents
08/19/2003CA2433180A1 Apoptosis promoting and suppressing substances interacting with cgi-94, and methods for screening the same
08/19/2003CA2142819C Glucagon receptors
08/19/2003CA2138258C Synthetic peptides for the treatment of myasthenia gravis
08/19/2003CA2119660C Amylase inhibitors
08/19/2003CA2111083C Novel peptides, their preparation and use
08/19/2003CA2098972C Isolation and characterization of the growth hormone releasing hormone receptor
08/19/2003CA2098588C Thrombolytic agent
08/19/2003CA2095854C Mycobacterium vaccae in the treatment of uveitis
08/19/2003CA2071674C Peptidyl derivatives as inhibitors of interleukin-1.beta. converting enzyme
08/19/2003CA2070254C Thrombin inhibitors
08/19/2003CA2066532C Pharmaceutical compositions
08/15/2003WO2004087941A1 Map-kinase inhibitors as regulators of tumor-associated antigen expression
08/15/2003CA2475206A1 Map-kinase inhibitors as regulators of tumor-associated antigen expression
08/14/2003WO2003067262A2 Methods and compositions involving the hsp90 activator aha1
08/14/2003WO2003067257A1 Individualization of therapy with anxiolitics
08/14/2003WO2003066892A1 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
08/14/2003WO2003066881A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/14/2003WO2003066877A2 Compositions and methods relating to hepatic specific genes and proteins
08/14/2003WO2003066862A1 Cloning of a human prolylhydroxylase-like protein
08/14/2003WO2003066860A1 Angiogenesis inhibitors
08/14/2003WO2003066859A2 Amino acid sequences capable of facilitating penetration across a biological barrier
08/14/2003WO2003066845A2 Bacteriophage lysin
08/14/2003WO2003066844A2 Cytochrome p450 protein
08/14/2003WO2003066842A2 Method for producing recombinant proteins in micro-organisms
08/14/2003WO2003066841A1 Viral variants with altered susceptibility to nucleoside analogs and uses thereof
08/14/2003WO2003066829A2 Factors for angiogenesis, vasculogenesis, cartilage formation, bone formation and methods of use thereof
08/14/2003WO2003066825A2 Modified pituitary gland development in offspring from expectant mother animals treated with growth hormone releasing hormone therapy
08/14/2003WO2003066824A2 Albumin-fused kunitz domain peptides
08/14/2003WO2003066822A2 Truncated aggrecanase molecules
08/14/2003WO2003066814A2 Peptide-dependent upregulation of telomerase expression
08/14/2003WO2003066807A2 Method of inhibiting pathogenicity of infectious agents
08/14/2003WO2003066805A2 Antisense modulation of complement component c3 expression
08/14/2003WO2003066680A2 Antigens for immunocontraception
08/14/2003WO2003066679A1 Rhamnose binding protein
08/14/2003WO2003066674A2 Viral cd30 polypeptide
08/14/2003WO2003066673A1 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof
08/14/2003WO2003066672A1 Peptides
08/14/2003WO2003066671A1 Heterocyclic compounds having elastase-inhibiting activity and intermediates thereof
08/14/2003WO2003066670A2 Dipeptides and tripeptides with anti-inflammatory activity
08/14/2003WO2003066666A2 Compositions and methods for treatment of vitamin d deficiency
08/14/2003WO2003066663A2 Peptides for recognition and targeting of glial cell tumors
08/14/2003WO2003066633A1 Novel pyranosyl cytosines: pharmaceutical formulations and methods
08/14/2003WO2003066587A2 Piperidine or pyrrolidine derivatives having an aminoacyl substituted side chain as melancortin-4 receptor agonists
08/14/2003WO2003066585A2 Polymer-based compositions for sustained release
08/14/2003WO2003066165A1 Tumor necrosis factor combined with interferon in demyelinating diseases
08/14/2003WO2003066104A2 Pharmaceutical composition which improves in vivo gene transfer
08/14/2003WO2003066103A1 Pharmaceutical compositions for hepatitis c viral protease inhibitors
08/14/2003WO2003066102A1 Immunocytokine-containing lyophilized preparation
08/14/2003WO2003066098A2 Snares and methods of controlling cytokinesis
08/14/2003WO2003066091A2 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7
08/14/2003WO2003066089A1 Megsin ligands
08/14/2003WO2003066088A2 Protease screening and novel use of proteases
08/14/2003WO2003066087A2 Kinases involved in the regulation of energy homeostasis
08/14/2003WO2003066086A2 Proteins involved in the regulation of energy homeostatis
08/14/2003WO2003066085A1 Albumin-fused anti-angiogenesis peptides
08/14/2003WO2003066084A1 Use of glp-1 compound for treatment of critically ill patients
08/14/2003WO2003066083A1 Preparations for treating bone fracture or bone loss or elevating bone density
08/14/2003WO2003066082A1 Use of the insulin-like-growth factor i splice variant mgf for the prevention of myocardial damage
08/14/2003WO2003066081A2 Bmp inhibitors for the treatment of spondyloarthropathies
08/14/2003WO2003066080A1 Compositions and methods for promoting lipid mobilization, glycogen mobilization, or both, in humans
08/14/2003WO2003066079A2 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds
08/14/2003WO2003066078A1 Hiv inhibiting proteins
08/14/2003WO2003066077A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
08/14/2003WO2003066048A2 Use of 15-lipoxygenase inhibitors for treating and preventing bone loss
08/14/2003WO2003066003A2 Anti-pathogen treatements
08/14/2003WO2003066002A2 IFN-a/b-INDEPENDENT MECHANISM OF ANTIVIRAL PROTECTION
08/14/2003WO2003066000A2 Formulation comprising bioactive agents and method of using same
08/14/2003WO2003065997A2 Anti-infarction molecules
08/14/2003WO2003065987A2 Granzyme b inhibitors
08/14/2003WO2003065985A2 Uses of mammalian cytokine; related reagents
08/14/2003WO2003065984A2 Methods and compositions for treating cardiovascular disease
08/14/2003WO2003065981A2 Therapeutic use for lp229, in particular for wound healing
08/14/2003WO2003065980A2 Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphin
08/14/2003WO2003065977A2 Modified antigen-presenting cells
08/14/2003WO2003065974A2 Hexa-, hepta-, and octapeptides having antiangiogenic activity
08/14/2003WO2003065973A2 Multivalent streptococcal vaccine compositions and methods for use
08/14/2003WO2003065972A2 Methods for screening osteogenic compounds
08/14/2003WO2003056909A3 Hair removal and animal husbandry method
08/14/2003WO2003048183A3 Method for obtaining oestrogen from mare urine
08/14/2003WO2003045325A3 Dopaminergic stimulatory factor
08/14/2003WO2003043647A3 A plant extract active as an immunostimulating agent
08/14/2003WO2003043586A3 Compositions for sustained action product delivery
08/14/2003WO2003041652A3 Method of using 18080, a human serine carboxypeptidase family member
08/14/2003WO2003038032A8 Means for inhibition of the synthesis of viral proteins
08/14/2003WO2003035845A3 Salvador tumor suppressor gene
08/14/2003WO2003032898A3 Modified human thymic stromal lymphopoietin
08/14/2003WO2003031575A3 A hybrid fusion protein transcription regulator to induce interferon target gene expression
08/14/2003WO2003031568A8 Intracellular signaling molecules
08/14/2003WO2003028637A3 Antisense modulation of sphingosine-1-phosphate lyase expression
08/14/2003WO2003027232A3 Method for producing biologically active products
08/14/2003WO2003022995A3 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
08/14/2003WO2003018768A3 Transmembrane protein differentially expressed in cancer
08/14/2003WO2003014303A3 Molecular interactions in cells
08/14/2003WO2003009813A3 Methods of treating neuropilin-mediated diseases
08/14/2003WO2003002713A3 Antibodies to opgl
08/14/2003WO2003000202A3 Particles for inhalation having rapid release properties
08/14/2003WO2002101048A3 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
1 ... 1791 1792 1793 1794 1795 1796 1797 1798 1799 1800 1801 1802 1803 1804 1805 1806 1807 1808 1809 1810 1811 ... 3163